Read + Share
Amedeo Smart
Independent Medical Education
Kallolimath S, Sun L, Palt R, Stiasny K, et al. Highly active engineered IgG3 antibodies against SARS-CoV-2. Proc Natl Acad Sci U S A 2021;118.PMID: 34599091
Email
LinkedIn
Facebook
Twitter
Privacy Policy